{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-112393","form_type":"8-K","ticker":"RVP","cik":"0000946563","company_name":"RETRACTABLE TECHNOLOGIES INC","filed_at":"2025-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.693905+00:00","generated_at":"2026-05-16T20:04:48.574628+00:00","sec_items":["8.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Retractable Q3 net sales $10.1M, operating loss $3.7M; receives Vizient designation","bullets":["Q3 net sales $10.1M (down from $10.3M YoY); operating loss $3.7M vs $5.1M loss last year.","Net income $371k in Q3 includes $2.4M unrealized gains on securities; 9-month net loss $10.2M.","Tariffs on needles from China at 130%; $2.3M spent on tariffs in first nine months of 2025.","U.S. manufacturing share rose to 38.3% in 2025 from 10% in 2024; workforce reductions implemented.","EasyPoint Blood Collection Tube Holder with Needle received Vizient Innovative Technology designation."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-112393","json":"https://secwatch.observer/filing/0001104659-25-112393.json","markdown":"https://secwatch.observer/filing/0001104659-25-112393.md","text":"https://secwatch.observer/filing/0001104659-25-112393.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/946563/000110465925112393/0001104659-25-112393-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/946563/000110465925112393/tm2531255d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T20:04:48.574628+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}